Jiangxi Synergy Pharmaceutical (300636.SZ) has obtained the European Pharmacopoeia Certification.
Tonghe Pharmaceutical (300636.SZ) announces that the company recently received the European Medicines Quality Management Agency (EDQM) certification...
Jiangxi Synergy Pharmaceutical (300636.SZ) announced that the company recently received the updated European Pharmacopoeia Compliance Certificate (CEP) for the active pharmaceutical ingredient Tenofovir Disoproxil Fumarate from the European Directorate for the Quality of Medicines (EDQM). The main reason for this update is the addition of a new production workshop, with the certification scope covering Tenofovir Disoproxil Fumarate. The updated certificate will take effect from September 12, 2025.
Related Articles
GREENTOWN MGMT (09979) spent HK$944,200 to repurchase 300,000 shares on September 16th.
Anzheng Fashion Group (603839.SH) plans to concentrate on competitive bidding to reduce its repurchased shares by no more than 1,870,000 shares.
Sichuan Guangan AAA Public (600979.SH) intends to acquire 90% of the equity of Qitai Hengtuo to expand its wind power generation business.
GREENTOWN MGMT (09979) spent HK$944,200 to repurchase 300,000 shares on September 16th.
Anzheng Fashion Group (603839.SH) plans to concentrate on competitive bidding to reduce its repurchased shares by no more than 1,870,000 shares.
Sichuan Guangan AAA Public (600979.SH) intends to acquire 90% of the equity of Qitai Hengtuo to expand its wind power generation business.
